Xtant Medical Holdings (XTNT) Capital Expenditures (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Capital Expenditures data on file, last reported at $430000.0 in Q3 2025.

• On a quarterly basis, Capital Expenditures fell 79.56% year-over-year to $430000.0 in Q3 2025; TTM through Sep 2025 was $2.7 million, a 30.1% decrease from a year earlier, with the FY2024 full-year figure at $4.1 million, up 182.49% from the prior year.
• Capital Expenditures for Q3 2025 stood at $430000.0, up from $366000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for XTNT reached as high as $2.1 million in Q3 2024 and fell as low as $223000.0 in Q3 2023.
• Historically, Capital Expenditures has averaged $601842.1 across 5 years, with a median of $484000.0 in 2022.
• Across the five-year window, Capital Expenditures soared 843.5% in 2024 and plunged 79.56% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $626000.0 in 2021, then dropped by 29.23% to $443000.0 in 2022, then declined by 18.06% to $363000.0 in 2023, then soared by 85.12% to $672000.0 in 2024, then plunged by 36.01% to $430000.0 in 2025.
• Per Business Quant data, the three most recent Capital Expenditures figures were $430000.0 in Q3 2025, $366000.0 in Q2 2025, and $1.2 million in Q1 2025.